Initiation of glucocorticoids before entering rheumatology care associates with long-term glucocorticoid use in older adults with early rheumatoid arthritis: A joint analysis of Medicare and the Rheumatology Informatics System for Effectiveness (RISE
GCs are regularly used in eRA and most often initiated before patients enter rheumatology care. Long-term, low-dose GC use is common and associated with initiation before rheumatology care. Earlier referral to rheumatology might reduce GC exposure among U.S. patients with eRA.
Authors
- Jinoos Yazdany (ORCID: https://orcid.org/0000-0002-3508-4094)
- Emma Kersey (ORCID: https://orcid.org/0009-0001-5637-7515)
- Gabriela Schmajuk (ORCID: https://orcid.org/0000-0003-2687-5043)
- Rachael Stovall (ORCID: https://orcid.org/0000-0002-0355-4020)
- Frank Buttgereit (ORCID: https://orcid.org/0000-0003-2534-550X)
- Andriko Palmowski (ORCID: https://orcid.org/0000-0002-3456-0597)
- Eric T. Roberts (ORCID: https://orcid.org/0009-0005-8435-8994)
- Jing Li
Institutions
- University of California, San Francisco (US)
- University of Washington (US)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Seminars in Arthritis and Rheumatism
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1016/j.semarthrit.2024.152535
- Citations
- 3
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 1.41
Funders
- Pfizer
- Gilead Sciences
- Horizon Therapeutics
- National Institutes of Health
- University of California, San Francisco
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Center for Advancing Translational Sciences